Urinary transferrin pre-emptively identifies the risk of renal damage posed by subclinical tubular alterations.
Casanova AG, Vicente-Vicente L, Hernández-Sánchez MT, Prieto M, Rihuete MI, Ramis LM, Del Barco E, Cruz JJ, Ortiz A, Cruz-González I, Martínez-Salgado C, Pescador M, López-Hernández FJ, Morales AI.
Casanova AG, et al. Among authors: pescador m.
Biomed Pharmacother. 2020 Jan;121:109684. doi: 10.1016/j.biopha.2019.109684. Epub 2019 Nov 25.
Biomed Pharmacother. 2020.
PMID: 31810121
Free article.